Syncope is caused by insufficient oxygen supply to the brain. There have been attempts to classify syncope on the basis of defects in the venous system, arterial system (that is impaired systemic vascular resistance) or a combination of the two (that is mixed). We examined the hypothesis that a comparable decrease in cerebral perfusion would be evident at pre-syncope irrespective of the category of dysfunction. Young healthy volunteers (N ¼ 37) participated. The protocol consisted of 15 min supine rest, followed by 601 head-up tilt and lower body suction in increments of À10 mm Hg for 5 min each until pre-syncope. Beat-to-beat blood pressure (BP) (Finometer or intra-arterial), cardiac output (Finometer), middle cerebral artery blood velocity (MCAv), end-tidal CO 2 and cerebral oxygenation were monitored continuously. At pre-syncope, mixed dysfunction was common (21 out of 37 participants), followed by venular dysfunction (15 out of 37 participants). In the venular and mixed groups, comparable orthostatic tolerance and declines in BP (À37 vs À43% from baseline, respectively), end-tidal PCO 2 , MCAv (À35 vs À38%) and cerebral oxygenation (À5 vs À7%) were evident despite distinct mechanisms purportedly being responsible for the hypotension. Although different determinants of hypotension do exist, cerebral hypoperfusion occurs to a similar extent.
Introduction
Orthostatic hypotension (OH) is defined as a reduction in systolic blood pressure (BP) of X20 mm Hg or a reduction in diastolic BP of X10 mm Hg within 3 min of undergoing orthostatic stress. 1 The typical symptoms of OH-wooziness, light-headedness, and visual dimming-are fundamentally caused by insufficient oxygen supply to the brain which, if sustained, results in syncope. Syncope refers to a transient loss of consciousness as a result of cerebral hypoperfusion with subsequent spontaneous recovery. 2 Pre-syncope may be described as a feeling of lightheadedness that precedes or almost results in collapse. Therefore, anything that compromises cerebral blood flow (CBF) may jeopardize the ability to maintain consciousness. 3 Visual dimming, for example, is due to reductions in blood flow in the opthalmic nerve, and therefore the changes responsible for the occurrence of such symptoms precede the critical reductions in flow to the reticular activating system in the brainstem, the area responsible for maintaining consciousness. 4 The prevalence of OH in the general population is significant (B3%) and recent reports indicate that the incidence of syncope is nearly twice as common in young age groups (o40 years) as in older age groups (460 years). 5 Although the underlying mechanisms are still unknown, some data indicate that OH results from inadequate compensatory responses of the venous system, that is impaired reflex constriction of the venous capacitance beds, [6] [7] [8] whereas other data suggest an underlying arterial vascular resistance deficit. 9, 10 Recently, it has been shown that, at least in young (20-40 years of age) patients with a history of OH, hypotension during routine tilt testing is cardiac output mediated, 11 rather than mediated by a fall in systemic vascular resistance. 12, 13 Because of these differential findings, in part, there have been recent attempts to classify OH into three possible subgroups on the basis of alterations in peripheral resistance and cardiac output at pre-syncope. 6, 14, 15 These subgroups include (1) defects in the venous system (that is excessive reductions in venous return); (2) defects in the arterial system (that is impaired vasoconstriction); and (3) a combination of the two (that is mixed). In older patients with OH, 14 it has been reported that venular defects affected the majority of patients (54%), compared with arterial (25%) and mixed defects (21%). It has not been clearly established, however, if a similar pattern of events occurs in younger humans. This is relevant because of the high prevalence of OH in young age groups (o40 years) as well as the well-known variability in the integrated haemodynamic responses to orthostatic stress. This variability does not necessarily reflect pathology associated with OH as such, but rather a 'normal' continuum of responses to orthostasis. The end of this 'variability' continuum, as recently reported 16 may well represent and be classified clinically by autonomic disorders such as the postural tachycardia syndrome, in which patients experience exaggerated increases in heart rate (HR) responses (X30 beats per min after 3 min) during head-up tilt (HUT). Moreover, the regulation of CBF in patients with OH may be quite different from that of healthy individuals, particularly when assessed during the rapidly changing haemodynamic conditions associated with vasovagal (reflex mediated) syncope. To be able to interpret the pathophysiological significance of these observations, a clear understanding of the normal responses of the cerebral circulation to orthostatic stress must be obtained, particularly in the context of the known changes in systemic and CBF distributions during orthostasis.
As symptoms and loss of consciousness during syncope are fundamentally due to cerebral hypoperfusion, 3 one limitation of this classification approach 6, 14, 15 is that it fails to consider the influence of these haemodynamic changes on cerebral perfusion. Moreover, these studies have not quantified the extent to which inappropriate hyperventilation at pre-syncope 17, 18 may further exacerbate imminent syncope. These limitations are noteworthy because the brain can effectively autoregulate, maintaining relatively constant CBF despite changes in arterial BP and is highly sensitive to changes in arterial PCO 2 . Furthermore, arterial BP does not necessarily reflect the cerebrovascular phenomena associated with syncope. 3 A more fundamental issue with this classification system is that it oversimplifies the complex physiology of orthostatic BP regulation: 19, 20 (see Discussion). Therefore, the main aim of this study was to provide a comprehensive examination of the cardiorespiratory and cerebrovascular changes associated with the previously reported classification of syncope. To delineate the 'normal' cardiorespiratory and cerebrovascular responses to pre-syncope, we used healthy humans free of known OH and induced pre-syncope by means of combining HUT and lower body suction. We examined the hypothesis that a comparable decrease in CBF would be evident at pre-syncope irrespective of category of dysfunction.
Methods
Thirty-seven healthy individuals [(19 men and 18 women) aged 25 ± 5 years (mean ± s.d.); body mass index 24.4±3.4 kg m À2 ] volunteered for this study, which was approved by the Human Ethics Committee of the University of Otago and conformed to the standards set by the Declaration of Helsinki. Subjects were informed of the experimental procedures and possible risks involved in the study and written informed consent was obtained. Subjects were not taking any medication, all were nonsmokers and none had any history of syncope, cardiovascular, cerebrovascular or respiratory diseases. None of our subjects had been previously clinically diagnosed with OH, and none described incidents of syncope and/or related symptoms in their daily lives.
Experimental design
Subjects were instructed to abstain from exercise, alcohol and caffeine 24 h before experimental testing, and not to eat a heavy meal 4 h prior. Subjects attended the laboratory on two occasions. The first occasion was used to familiarize the subjects with the tilt table and lower body negative pressure (LBNP) and related experimental apparatus. During the second visit, conducted at the same time of day and separated by 42 days from the familiarization, the main experimental testing was conducted. In female subjects, testing was not carried out at a specific phase of the menstrual cycle, as it has been shown that this does not affect orthostatic tolerance.
21,22
Measurements of CBF velocity, cerebral oxygenation, arterial BP and end-tidal gases During each session, CBF velocity, cerebral oxygenation, arterial BP, end-tidal carbon dioxide (P ET CO 2 ) and electrocardiography were recorded continuously. Blood flow velocity in the right middle cerebral artery was measured using a 2-MHz pulsed Doppler ultrasound system (DWL Doppler, Sterling VA, USA). The Doppler probe was maintained in position, at a fixed angle, using a commercially available headpiece. Cerebral oxygenation was monitored using a commercially available near infrared spectroscopy system (NIRO-200; Hamamatsu Photonics KK; Hamamatsu, Japan). A probe holder containing an emission probe and detection probe was attached at the right side of the forehead with a distance of 5 cm between the probes as described earlier. 23 Beat-to-beat BP was measured by finger photoplethysmography (Finometer, TPD Biomedical Instruments, Netherlands) or, in an additional subgroup (n ¼ 8), intra-arterially (see: Validation of noninvasive beat-to-beat BP). During both the supine rest and tilt, subjects were instructed to keep their hand at waist level. The Finometer uses a height correction system, whereby any changes in vertical displacement of the finger cuff relative to the heart are corrected for by a reference probe placed on the chest at the fourth intercostal space in the midclavicular line (heart level). From the BP waveform, stroke volume (SV) and cardiac output ( . Q) were calculated using the Model Flow method, which incorporates gender, age, height and mass data (BeatScope 1.0 software; TNO; TPD Biomedical Instruments; Netherlands). It is not clear, however, if absolute measurements of SV by the Model Flow method are valid during conditions of syncope; thus emphasis of these data are placed on the relative changes with progressive orthostatic stress. As used in other studies, 24, 25 middle cerebral artery blood velocity (MCAv) and BP were expressed as the percentage change from this baseline to enable the same relative comparisons and to reduce inter-individual variability unrelated to the experimental manipulation. Participants breathed through a respiratory mask attached to a one-way nonrebreathing valve and P ET CO 2 and P ET O 2 were sampled continuously and measured using a gas analyser (model CD-3A, AEI Technologies, Pittsburgh, PA, USA). HR was also recorded using three-lead electrocardiogram via a Bio Amp (Model ML132, ADInstruments, Colorado Springs, CO, USA). All data were sampled continuously at 200 Hz using an analog-digital converter (Powerlab/16SP ML795; ADInstruments) interfaced with a computer and displayed in real time during testing. Total peripheral resistance (TPR) was calculated as mean arterial BP (MAP)/ . Q. Cerebrovascular resistance was calculated as MAP/MCAv.
HUT and LBNP
Subjects were placed on the combined HUT and LBNP table and rested supine for at least 15 min. Subjects were then tilted to 601 for 5 min where they remained until termination of the subsequent LBNP protocol. Lower body suction was applied in À10 mm Hg incremental steps for 5 min each. 26 Testing was terminated on participant's request due to subjective symptoms of pre-syncope (feelings of dizziness, nausea, faintness), or when a continuous drop in systolic BP below 80 mm Hg for 410 s was observed. Although many earlier studies have used the o80 mm Hg as the cutoff point, 26 data from our laboratory indicate that respiratory-induced swings in BP occur, especially at BPs between 75 and 85 mm Hg. These less conservative criteria of termination of the syncope protocol allowed better monitoring of physiological changes immediately before syncope.
Validation of noninvasive beat-to-beat BP and end-tidal PCO 2 In eight additional subjects, following local anaesthesia (1% lidocaine), arterial pressure was measured with a radial arterial catheter (Abbott Critical Care System, Abbott Park, IL, USA) together with the noninvasive finger photoplethysmography method to corroborate changes in arterial pressure.
Methods. At baseline, during the last minute of 601 upright tilt and near pre-syncope, a small portion (2 ml) of the arterial blood was sampled into chilled heparin syringes for immediate measurement, in duplicate, of arterial blood gases (NPT Series, Radiometer, Copenhagen, Denmark). Before sampling, a 1 ml of dead-space blood was discarded. Commercial standards were used to calibrate the blood gas analyser before starting the tests. The reproducibility of the blood gas measurements at rest was assessed from the coefficient of variation of the difference between the two baseline collections divided by 2. 27 The within-test coefficient of variation for arterial PCO 2 was o0.5%. P ET CO 2 was averaged over the 20-s period during the arterial blood draws.
Results. At supine rest, small absolute differences of B3 mm Hg in MAP (Po0.05) were found between the measurements of radial and finger arterial pressure. However, the magnitude of decline in arterial pressure monitored by the Finometer and direct intra-arterial line were comparable at presyncope (MAP: 41% by Finometer, 42% by catheter; P40.05). In addition, at rest and close to pre-syncope, the declines in P ET CO 2 tracked ( ± 1.4 mm Hg) the declines in arterial PCO 2 (P40.05) (also see: Methodological considerations).
Classification of syncope
The subjects were categorized into three groups: arteriolar, venular or mixed, based on changes in TPR and . Q during HUT-LBNP. 6, 14, 15 In brief, venular dysfunction was defined as a drop in . Q despite a compensatory increase in TPR, which led to a drop in MAP (this is characterized by a drop in venous return and therefore a drop in SV and CO, with an accompanying increase in HR). Arteriolar dysfunction was defined by a drop (or no change) in TPR (evidence of impaired arteriolar vasoconstriction), which led to a drop in MAP despite an increase (or no change) in . Q. The mixed dysfunction category is described as arteriolar and venular dysfunction occurring simultaneously (Table 1) . A change of X10% in TPR or . Q was taken to be significant to categorize subjects during HUT-LBNP. 
Assessment of orthostatic tolerance
Orthostatic tolerance was assessed using two complementary measures: (1) the time to pre-syncope and (2) a cumulative stress index, 28, 29 which was calculated for each participant as the sum of the products of the duration of LBNP and the magnitude of the negative pressure at each level (mm Hg Â min).
Data and statistical analysis
All related values presented in Tables 1 and 2 and Figures 1-3 Values are expressed as mean ± s.d. based on (n ¼ 37). The Cumulative Stress Index was calculated as the sum of the products of the duration of LBNP and the magnitude of the negative pressure at each level (mm Hg Â min). There were no between-group differences. Figure 1 Baseline and pre-syncope values for (a) CBF velocity, MCAv; and (b) cerebral oxygenation for all subjects in the venular and mixed groups. There were no differences in baseline values in the two groups. Likewise, both MCAv and cerebral oxygenation were decreased (Po0.05) at pre-syncope to a similar degree in both groups. Figure 2 Change from baseline at pre-syncope in (a) mean arterial pressure, MAP; and (b) heart rate, HR for all subjects in the venular and mixed groups. Mean values were not significantly different.
Results

Syncope classification
The majority of the group (57%; 21 out of 37 participants) exhibited mixed dysfunction, in which arteriolar and venular dysfunction occur simultaneously. Venular dysfunction occurred in 41% (15 of 37) of the group, reflected as a drop in . Q despite a compensatory increase in TPR, which lead to a drop in MAP. The remaining subject fell into the arteriolar dysfunction category, manifested as a drop in TPR, which led to a drop in MAP despite little change in . Q. There was a large variation in presyncopal values of TPR and . Q, which lead to large standard deviations; however, these deviations were directional and so classification was still possible. For example, in the venular group, the increase in TPR ranged from 10 to 63%. Examination of venular and mixed dysfunction groups at baseline revealed that there were no differences in any of the measured cardiorespiratory and cerebrovascular variables (Table 3 ; Figures 1 and 2 ).
HUT and LBNP
All of the participants experienced pre-syncope as defined by a drop in SBP below 80 mm Hg for 410 s and marked subjective symptoms of pre-syncope. At pre-syncope, changes in the TPR and . Q were significantly different between the venular and mixed groups (16 vs À8%; and À45 and À37%, respectively, Po0.05; Figure 3 ). MCAv was reduced by 35 and 38% in the venular and mixed groups at pre-syncope, and cerebral oxygenation by 5 and 7%, respectively (see Table 2 and Figure 1) . A similar drop in MAP was also seen at pre-syncope, À31 mm Hg in the venular group and À36 mm Hg in the mixed group, which corresponded to 37 and 43% from baseline (P40.05; Figure 2 ). These presyncopal changes are similar to those reported elsewhere in the literature. 30 Comparable reductions in end-tidal PCO 2 were evident with no betweengroup classification differences (Table 2) .
Orthostatic tolerance
The mean CSI ( ± s.d.) tolerated was 468 ± 304 in the venular group and 618±372 in the mixed group, with no difference between groups (P40.05).
Discussion
The two main novel findings of this study are (1) supportive of our primary hypothesis, OH classified as venular or mixed dysfunction manifested in a comparable degree of cerebral hypoperfusion; (2) in contrast to patients with diagnosed OH, 14 mixed dysfunction was the most common sequence of events leading to pre-syncope, followed by venular dysfunction.
Classification of syncope
In patients with orthostatic intolerance, some studies indicate that OH results from inadequate compensatory responses of the venous system, whereas others suggest an underlying arterial vascular resistance deficit. 9, 10 Our results, in volunteers free of OH, show that the majority of this cohort exhibited mixed (that is combined arteriolar/venular) dysfunction (56.8%) or venular dysfunction (40.5%). These findings contrast with the findings in patients with OH in which venular defects affected the majority (54%), compared with arterial (25%) and mixed effects (21%).
14 More recently, Verheyden et al. 11 showed that in patients with vasovagal syncope, pre-syncope appeared to result from a radical drop in . Q (BÀ50%) and TPR was statistically unchanged across the patient population. Although this study did not show individual data or indicate if any of the patients might have had a fall in systemic vascular resistance, 11 these results are broadly comparable to this study where . Q declined by BÀ42±12% at pre-syncope; however, there was a significantly greater reduction in . Q in the venular group. Importantly, however, despite the apparent failure of different systems to maintain BP, comparable orthostatic tolerance and similar Figure 3 Change from baseline in (a) total peripheral resistance, TPR; and (b) cardiac output, CO for all subjects in the venular and mixed groups. Mean values were significantly different between the groups, 3.1 vs À1.2 mm Hg l À1 min for total peripheral resistance and À3.6 vs À2.5 l min À1 for cardiac output in the venular and mixed groups, respectively (*Po0.05).
decreases in MAP, MCAv and cerebral oxygenation were evident during mixed and venular dysfunction at pre-syncope. A critical point is that this basic categorization by primary cause of hypotension fails to account for the complex physiology of orthostatic BP regulation. For example, changes in systemic vascular resistance and cardiac output are not exclusive compensatory mechanisms. 19, 20 A fall in systemic vascular resistance in the splanchnic bed might result in translocation of blood to the venous system and a consequential decrease in cardiac output; thereby these responses may interact in an attempt to prevent syncope. Thus, arteriolar dysfunction might underlie, in part, what the earlier authors 6, 14, 15 have classified as 'venular dysfunction'. Therefore, this method of categorization of syncope should be treated with caution.
Mechanisms of syncope
Although the exact pathophysiological mechanisms leading to the occurrence of syncope are still unknown, 31 reflex-mediated factors, physical factors or a combination of these are thought to be involved. 32 Traditionally, it has been thought that syncope is chiefly caused by hypotension produced by decreased systemic vascular resistance. 12, 13 Recently, this concept has evolved to allow for a precipitous fall in . Q to be at least equally responsible for the observed hypotension. 11 Both the traditional and more recent theories are limited because they fail to consider that symptoms and loss of consciousness during syncope are fundamentally due to cerebral hypoperfusion. There are three fundamental limitations: first, because of effective cerebral autoregulation, arterial BP does not necessarily reflect the cerebrovascular phenomena associated with syncope. 3 Second, hypotension as the primary cause of syncope fails to consider the well-documented occurrence of hyperventilation before the onset of syncope. 33, 34 For example, it has been reported that respiratory instability and hypocapnia impair cerebral perfusion during pre-syncope in patients with orthostatic intolerance. 17, 18 Although these studies did not attempt to classify the type of syncope, our findings confirm and extend this report to show that such changes can occur in the absence of pathology, irrespective . Q and BP contributes to the reduction in CBF during syncope is not known. The complex interactions between cardiorespiratory and cerebrovascular physiology are integral to the pathophysiology of syncope, and lie at a junction between cardiology, neurology and respiratory medicine. Consequently, more complete understanding of these interactions in health and disease will require increased cooperation between researchers who conventionally work in separate disciplines. Ultimately, however, we caution the use of the previously described classification system, 6, 14, 15 because it fails to consider many of complex factors associated with syncope.
Methodological considerations
We estimated changes in TPR and . Q using the Modelflow method. 40 The Modelflow method assumes a population average of aortic area depending on gender, age, height and weight. Several studies have validated the Modelflow method compared with standard invasive techniques and indicate that this method provides a reliable estimate of changes in cardiac output in a variety of physiological 41 and pathological 42, 43 conditions. Moreover, it has been shown that after calibration, the tracking of changes in SV and . Q with Model Flow vs thermodilutionbased estimate changes compared within 5 ± 2% during prolonged tilt testing 44 (also see Verheyden, et al., 11 for further details). Although our noninvasive estimates of BP compare well with those recorded intra-arterially, it should be noted that, as TPR is estimated by the Model Flow method, it is not possible to completely differentiate the venous contribution from the arterial system. For example, although TPR is always calculated as the quotient of mean BP and . Q, we cannot be sure that this quotient, measured by any invasive or noninvasive method, is a true expression of the arterial tone. Moreover, even if the arterial tone is much higher than the venous tone, the estimated TPR does not allow us to absolutely differentiate the venous contribution from that of the arterial system (especially if a fall in systemic vascular resistance in the splanchnic bed might result in translocation of blood to the venous system and thereby in a decrease in cardiac output). Nevertheless, it would seem unlikely that the unavoidable technical limitations with using estimated TPR and . Q, as used extensively in other studies, would explain the differential mechanisms causing hypotension in the classification system. We used Doppler ultrasound to measure flow velocity, rather than blood flow, in MCA; nevertheless, earlier reports indicate that MCAv is a reliable index of CBF during both changes in arterial PCO 2 45-47 and orthostatic stress. 48 Finally, the NIRS monitors oxygenation in tissue and confirms the capillary-oxygen-level-dependent related increase in oxygenation observed by functional magnetic resonance imaging during neural activation. 49 We acknowledge that NIRS measures only local (that is to one depth) oxygenation and that discreet regions of the brain may respond differently during orthostatic stress.
To rule out the potential uncertainty about the use of noninvasive end-tidal PCO 2 and BP monitoring, we confirmed the adequacy of these noninvasive measures with direct PaCO 2 and BP at rest and that close to the point of pre-syncope. Although our comparisons seem to contradict two other studies in which end-tidal PCO 2 changes overestimated arterial PCO 2 during tilt, 50, 51 there are some relevant experimental differences between these studies and ours. For example, end-tidal PCO 2 and arterial PCO 2 comparisons were made at rest and during standing upright 51 and during 10 min of 851 upright tilt. 50 Because of the lesser degree of orthostatic stress compared with that of this study, the degree of hypocapnia in these studies was rather modest (BÀ1.1 to À3.0 mm Hg) compared with this study (BÀ1.3 to À17.3 mm Hg). Our findings indicate the close tracking of end-tidal PCO 2 with arterial PCO 2 during a comparable degree of hypocapnia, which is highly consistent with an earlier study from our laboratory. 35 Thus, potentially because of the greater degree of orthostatic stress and hypocapnia, our findings are the first to provide additional insight that there is good agreement between end-tidal PCO 2 and arterial PCO 2 measurements at the point near syncope.
Implications
Our findings provide insight into the integrative events that occur during orthostatic stress in healthy subjects, and in particular, help to elucidate the changes in cerebral perfusion in the period preceding syncope. Our findings indicate that whether presyncope is provoked by defects in venular function or both venular and arteriolar dysfunction together, cerebral hypoperfusion occurs to a similar extent, thereby facilitating the onset of syncope, and that the type of dysfunction itself is of lesser importance. Moreover, because of interactions between systemic vascular resistance and cardiac output, and failure of the classification system 6, 14, 15 to reflect the complex physiological changes associated with syncope (for example, cerebral perfusion and hypocapnia), we caution its use for the meaningful assessment of OH. Future studies are needed to further develop the classification of syncope with specific focus on integrative assessment of cardiorespiratory and cerebrovascular function.
